{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:04:08Z","timestamp":1790240648180,"version":"4.1.0"},"reference-count":27,"publisher":"Baskent University","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.6002\/ect.2021.0475","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T03:23:05Z","timestamp":1653362585000},"page":"680-686","source":"Crossref","is-referenced-by-count":2,"title":["Therapeutic Plasma Exchange in Pediatric Patients With Sinusoidal Obstruction Syndrome\/Veno-Occlusive Disease After Hematopoietic Stem Cell Transplantation: A Single-Center Experience"],"prefix":"10.6002","volume":"20","author":[{"given":"Burcu","family":"Ak\u0131nc\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didem","family":"Atay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Demir Yenig\u00fcrb\u00fcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzu","family":"Ak\u00e7ay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcly\u00fcz","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4021","reference":[{"key":"ref0","unstructured":"References"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"1. Corbacioglu S, Carreras E, Ansari M, et al. Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation. Bone Marrow Transplant. 2018;53(2):138-145. doi:10.1038\/bmt.2017.161","DOI":"10.1038\/bmt.2017.161"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"2. Al Jefri AH, Abujazar H, Al-Ahmari A, et al. Veno-occlusive disease\/sinusoidal obstruction syndrome after haematopoietic stem cell transplantation: Middle East\/North Africa regional consensus on prevention, diagnosis and management. Bone Marrow Transplant. 2017;52(4):588-591. doi:10.1038\/bmt.2016.300","DOI":"10.1038\/bmt.2016.300"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"3. Dalle JH, Giralt SA. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: risk factors and stratification, prophylaxis, and treatment. Biol Blood Marrow Transplant. 2016;22(3):400-409. doi:10.1016\/j.bbmt.2015.09.024","DOI":"10.1016\/j.bbmt.2015.09.024"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"4. Mahadeo KM, Bajwa R, Abdel-Azim H, et al. Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement. Lancet Haematol. 2020;7(1):e61-e72. doi:10.1016\/S2352-3026(19)30201-7","DOI":"10.1016\/S2352-3026(19)30201-7"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"5. Schots R, Kaufman L, Van Riet I, et al. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation. Leukemia. 2003;17(6):1150-1156. doi:10.1038\/sj.leu.2402946","DOI":"10.1038\/sj.leu.2402946"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"6. Coppell JA, Brown SA, Perry DJ. Veno-occlusive disease: cytokines, genetics, and haemostasis. Blood Rev. 2003;17(2):63-70. doi:10.1016\/s0268-960x(03)00002-x","DOI":"10.1016\/S0268-960X(03)00002-X"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"7. Pham HP, Staley EM, Schwartz J. Therapeutic plasma exchange - a brief review of indications, urgency, schedule, and technical aspects. Transfus Apher Sci. 2019;58(3):237-246. doi:10.1016\/j.transci.2019.04.006","DOI":"10.1016\/j.transci.2019.04.006"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"8. Reeves HM, Winters JL. The mechanisms of action of plasma exchange. Br J Haematol. 2014;164(3):342-351. doi:10.1111\/bjh.12629","DOI":"10.1111\/bjh.12629"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"9. Mohty M, Malard F, Abecassis M, et al. Sinusoidal obstruction syndrome\/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 2015;50(6):781-789. doi:10.1038\/bmt.2015.52","DOI":"10.1038\/bmt.2015.52"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"10. Bonifazi F, Barbato F, Ravaioli F, et al. Diagnosis and treatment of VOD\/SOS after allogeneic hematopoietic stem cell transplantation. Front Immunol. 2020;11:489. doi:10.3389\/fimmu.2020.00489","DOI":"10.3389\/fimmu.2020.00489"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"11. Richardson PG, Carreras E, Iacobelli M, Nejadnik B. The use of defibrotide in blood and marrow transplantation. Blood Adv. 2018;2(12):1495-1509. doi:10.1182\/bloodadvances.2017008375","DOI":"10.1182\/bloodadvances.2017008375"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"12. Richardson PG, Smith AR, Triplett BM, et al. Earlier defibrotide initiation post-diagnosis of veno-occlusive disease\/sinusoidal obstruction syndrome improves day +100 survival following haematopoietic stem cell transplantation. Br J Haematol. 2017;178(1):112-118. doi:10.1111\/bjh.14727","DOI":"10.1111\/bjh.14727"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"13. Dignan FL, Wynn RF, Hadzic N, et al. BCSH\/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation. Br J Haematol. 2013;163(4):444-457. doi:10.1111\/bjh.12558","DOI":"10.1111\/bjh.12558"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"14. Faraci M, Bertaina A, Luksch R, et al. Sinusoidal obstruction syndrome\/veno-occlusive disease after autologous or allogeneic hematopoietic stem cell transplantation in children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group. Biol Blood Marrow Transplant. 2019;25(2):313-320. doi:10.1016\/j.bbmt.2018.09.027","DOI":"10.1016\/j.bbmt.2018.09.027"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"15. Kernan NA, Grupp S, Smith AR, et al. Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease\/sinusoidal obstruction syndrome. Br J Haematol. 2018;181(6):816-827. doi:10.1111\/bjh.15267","DOI":"10.1111\/bjh.15267"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"16. Carreras E, Diaz-Beya M, Rosinol L, Martinez C, Fernandez-Aviles F, Rovira M. The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade. Biol Blood Marrow Transplant. 2011;17(11):1713-1720. doi:10.1016\/j.bbmt.2011.06.006","DOI":"10.1016\/j.bbmt.2011.06.006"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"17. Yoon JH, Yoo KH, Sung KW, et al. Validation of treatment outcomes according to revised severity criteria from European Society for Blood and Marrow Transplantation (EBMT) for sinusoidal obstruction syndrome\/veno-occlusive disease (SOS\/VOD). Bone Marrow Transplant. 2019;54(8):1361-1368. doi:10.1038\/s41409-019-0492-6","DOI":"10.1038\/s41409-019-0492-6"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"18. Padmanabhan A, Connelly-Smith L, Aqui N, et al. Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the Writing Committee of the American Society for Apheresis: the eighth special issue. J Clin Apher. 2019;34(3):171-354. doi:10.1002\/jca.21705","DOI":"10.1002\/jca.21705"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"19. Fujimaru T, Ito S, Masuda H, et al. Decreased levels of inflammatory cytokines in immunoglobulin-resistant Kawasaki disease after plasma exchange. Cytokine. 2014;70(2):156-160. doi:10.1016\/j.cyto.2014.07.003","DOI":"10.1016\/j.cyto.2014.07.003"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"20. Knaup H, Stahl K, Schmidt BMW, et al. Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers. Crit Care. 2018;22(1):285. doi:10.1186\/s13054-018-2220-9","DOI":"10.1186\/s13054-018-2220-9"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"21. Iwai H, Nagaki M, Naito T, et al. Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure. Crit Care Med. 1998;26(5):873-876. doi:10.1097\/00003246-199805000-00021","DOI":"10.1097\/00003246-199805000-00021"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"22. Tesar V, Jelinkova E, Jirsa M, Jr., Bakosova M, Pitha P, Chabova V. Soluble adhesion molecules and cytokines in patients with myasthenia gravis treated by plasma exchange. Blood Purif. 2000;18(2):115-120. doi:10.1159\/000014434","DOI":"10.1159\/000014434"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"23. Stahl K, Schmidt JJ, Seeliger B, et al. Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock. Crit Care. 2020;24(1):71. doi:10.1186\/s13054-020-2799-5","DOI":"10.1186\/s13054-020-2799-5"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"24. Maheshwari A, Bajpai M, Patidar GK. Effects of therapeutic plasma exchange on liver function test and coagulation parameters in acute liver failure patients. Hematol Transfus Cell Ther. 2020;42(2):125-128. doi:10.1016\/j.htct.2019.05.003","DOI":"10.1016\/j.htct.2019.05.003"},{"key":"ref25","unstructured":"25. Besisik SK, Ozturk GB, Caliskan Y, Sargin D. Complete resolution of transplantation-associated thrombotic microangiopathy and hepatic veno-occlusive disease by defibrotide and plasma exchange. Turk J Gastroenterol. 2005;16(1):34-37."},{"issue":"2","key":"ref26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.17925\/EOH.2018.14.2.105","article-title":"Centrifugal and membrane therapeutic plasma exchange-a mini-review","volume":"14","author":"Janssens ME","year":"2018","unstructured":"26. Janssens ME WS. Centrifugal and membrane therapeutic plasma exchange-a mini-review. Eur Oncol Haematol 2018;14(2):105-109.","journal-title":"Eur Oncol Haematol"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T08:03:11Z","timestamp":1659600191000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/detail\/archive\/2022\/20\/7\/0\/680\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2021.0475","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}